Literature DB >> 32074253

Cognitive Impairment in Never-Medicated Individuals on the Schizophrenia Spectrum.

Rodolfo Solís-Vivanco1, Felipe Rangel-Hassey2, Pablo León-Ortiz3, Alejandra Mondragón-Maya4, Francisco Reyes-Madrigal3, Camilo de la Fuente-Sandoval3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32074253      PMCID： PMC7042924          DOI： 10.1001/jamapsychiatry.2020.0001

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  6 in total

1.  Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program.

Authors:  John M Kane; Delbert G Robinson; Nina R Schooler; Kim T Mueser; David L Penn; Robert A Rosenheck; Jean Addington; Mary F Brunette; Christoph U Correll; Sue E Estroff; Patricia Marcy; James Robinson; Piper S Meyer-Kalos; Jennifer D Gottlieb; Shirley M Glynn; David W Lynde; Ronny Pipes; Benji T Kurian; Alexander L Miller; Susan T Azrin; Amy B Goldstein; Joanne B Severe; Haiqun Lin; Kyaw J Sint; Majnu John; Robert K Heinssen
Journal:  Am J Psychiatry       Date:  2015-10-20       Impact factor: 18.112

2.  Neurocognition and Duration of Psychosis: A 10-year Follow-up of First-Episode Patients.

Authors:  Bjørn Rishovd Rund; Helene Eidsmo Barder; Julie Evensen; Ulrik Haahr; Wenche ten Velden Hegelstad; Inge Joa; Jan Olav Johannessen; Johannes Langeveld; Tor Ketil Larsen; Ingrid Melle; Stein Opjordsmoen; Jan Ivar Røssberg; Erik Simonsen; Kjetil Sundet; Per Vaglum; Thomas McGlashan; Svein Friis
Journal:  Schizophr Bull       Date:  2015-06-21       Impact factor: 9.306

3.  Association of Age at Onset and Longitudinal Course of Prefrontal Function in Youth With Schizophrenia.

Authors:  Tara A Niendam; Kimberly L Ray; Ana-Maria Iosif; Tyler A Lesh; Stefania R Ashby; Pooja K Patel; Jason Smucny; Emilio Ferrer; Marjorie Solomon; J Daniel Ragland; Cameron S Carter
Journal:  JAMA Psychiatry       Date:  2018-12-01       Impact factor: 21.596

4.  Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis.

Authors:  Bjørn Rishovd Rund; Ingrid Melle; Svein Friis; Tor K Larsen; Liv Jaeger Midbøe; Stein Opjordsmoen; Erik Simonsen; Per Vaglum; Thomas McGlashan
Journal:  Am J Psychiatry       Date:  2004-03       Impact factor: 18.112

5.  Mapping Thalamocortical Functional Connectivity in Chronic and Early Stages of Psychotic Disorders.

Authors:  Neil D Woodward; Stephan Heckers
Journal:  Biol Psychiatry       Date:  2015-07-02       Impact factor: 13.382

6.  Cognitive Change in Schizophrenia and Other Psychoses in the Decade Following the First Episode.

Authors:  Jolanta Zanelli; Josephine Mollon; Sven Sandin; Craig Morgan; Paola Dazzan; Izabela Pilecka; Tiago Reis Marques; Anthony S David; Kevin Morgan; Paul Fearon; Gillian A Doody; Peter B Jones; Robin M Murray; Abraham Reichenberg
Journal:  Am J Psychiatry       Date:  2019-07-01       Impact factor: 19.242
  6 in total
  7 in total

Review 1.  Abnormal synaptic plasticity and impaired cognition in schizophrenia.

Authors:  Xiu-Lin Wu; Qiu-Jin Yan; Fan Zhu
Journal:  World J Psychiatry       Date:  2022-04-19

2.  Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia.

Authors:  Yash B Joshi; Michael L Thomas; David L Braff; Michael F Green; Ruben C Gur; Raquel E Gur; Keith H Nuechterlein; William S Stone; Tiffany A Greenwood; Laura C Lazzeroni; Laura R MacDonald; Juan L Molina; John A Nungaray; Allen D Radant; Jeremy M Silverman; Joyce Sprock; Catherine A Sugar; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; Neal R Swerdlow; Gregory A Light
Journal:  Am J Psychiatry       Date:  2021-05-14       Impact factor: 19.242

3.  Cognitive deficits and white matter abnormalities in never-treated first-episode schizophrenia.

Authors:  Mi Yang; Shan Gao; Xiangyang Zhang
Journal:  Transl Psychiatry       Date:  2020-11-02       Impact factor: 6.222

4.  Effectiveness of using calligraphic activity to treat people with schizophrenia: a randomized controlled trial in Southern Taiwan.

Authors:  Wen-Yi Huang; Hector W H Tsang; Shu-Mei Wang; Yu-Chen Huang; Yi-Chun Chen; Chih-Heng Cheng; Chih-Yin Chen; Jung-Sheng Chen; Yen-Ling Chang; Ru-Yi Huang; Chung-Ying Lin; Marc N Potenza; Amir H Pakpour
Journal:  Ther Adv Chronic Dis       Date:  2022-03-11       Impact factor: 5.091

Review 5.  Pharmacological interventions to diminish cognitive side effects of electroconvulsive therapy: A systematic review and meta-analysis.

Authors:  Joey P A J Verdijk; Mike A van Kessel; Matthijs Oud; Charles H Kellner; Jeannette Hofmeijer; Esmée Verwijk; Jeroen A van Waarde
Journal:  Acta Psychiatr Scand       Date:  2022-02-08       Impact factor: 7.734

6.  Plasma metabolomics of schizophrenia with cognitive impairment: A pilot study.

Authors:  Yihe Jiang; Xiujia Sun; Miaowen Hu; Lei Zhang; Nan Zhao; Yifeng Shen; Shunying Yu; Jingjing Huang; Huafang Li; Wenjuan Yu
Journal:  Front Psychiatry       Date:  2022-09-28       Impact factor: 5.435

Review 7.  Heterogeneous trajectories in schizophrenia: insights from neurodevelopment and neuroprogression models.

Authors:  Ramiro Reckziegel; Letícia S Czepielewski; Mathias Hasse-Sousa; Dayane S Martins; Maria J de Britto; Clara de O Lapa; Alexandre W Schwartzhaupt; Clarissa S Gama
Journal:  Braz J Psychiatry       Date:  2022 Jan-Feb       Impact factor: 2.697
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.